The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients.
| Image |  |
|---|---|
| Description | scientific article published in November 2017 |
| Author/s |
author: Philip Manma Kolo |
| Publication date | November 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |